Publications by authors named "Daniel P Silver"

Claim this Profile
M
MECP2-Dependent Cancers Can Be Targeted by Epigenetic Drugs: A New Role for Epigenetic Cancer Therapy.
Manish Neupane, Mukesh Kumar, Malela A Mwamufiya, Colleen M Donnelly, Alsu Ibragimova, Daniel P Silver

Mol Cancer Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PARP Inhibitors for the Treatment of BRCA1/2-Mutated Metastatic Breast Cancer: A Systematic Review and Meta-analysis.
Ranju Kunwor, Daniel P Silver, Maysa Abu-Khalaf

Hematol Oncol Stem Cell Ther· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Aberrations in Circulating Tumor DNAs from Palbociclib-Treated Metastatic Breast Cancer Patients Reveal a Novel Resistance Mechanism.
Maysa Abu-Khalaf, Chun Wang, Zhenchao Zhang, Rui Luo, Weelic Chong, Daniel P Silver

Cancers (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duodenal and Biliary Obstruction due to Extrinsic CompressionDuodenal and Biliary Obstruction due to Extrinsic Compression by Recurrent Lobular Breast Carcinoma: A Case Report.
Rukaiya Bashir Hamidu, Bilal Asif, Harish Lavu, Thomas Kowalski, Daniel P Silver

Case Rep Gastroenterol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole-exome sequencing identifies somatic mutations and intratumor heterogeneity in inflammatory breast cancer.
Rui Luo, Weelic Chong, Qiang Wei, Zhenchao Zhang, Chun Wang, Daniel P Silver

NPJ Breast Cancer· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Tumor-Infiltrating Lymphocytes with Homologous Recombination Deficiency and Status in Patients with Early Triple-Negative Breast Cancer: A Pooled Analysis.
Melinda L Telli, Charles Chu, Sunil S Badve, Shaveta Vinayak, Daniel P Silver

Clin Cancer Res· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of HER2 status on circulating tumor cells in advanced-stage breast cancer patients with HER2-negative tumors.
Chun Wang, Zhaomei Mu, Zhong Ye, Zhenchao Zhang, Maysa M Abu-Khalaf, Daniel P Silver

Breast Cancer Res Treat· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuroendocrine Tumors Are Enriched in Cowden Syndrome.
Alison Greidinger, Susan Miller-Samuel, Veda N Giri, Michele Sue-Ann Woo, Saranya Akumalla, Daniel P Silver

JCO Precis Oncol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of clinical outcomes in metastatic breast cancer patients with circulating tumour cell and circulating cell-free DNA.
Zhong Ye, Chun Wang, Shaogui Wan, Zhaomei Mu, Zhenchao Zhang, Daniel P Silver

Eur J Cancer· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zoledronic acid alters hematopoiesis and generates breast tumor-suppressive bone marrow cells.
Jessalyn M Ubellacker, Marie-Therese Haider, Molly J DeCristo, Gloria Allocca, Nicola J Brown, Daniel P Silver

Breast Cancer Res· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer.
Melinda L Telli, Kirsten M Timms, Julia Reid, Bryan Hennessy, Gordon B Mills, Daniel P Silver

Clin Cancer Res· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MECP2 Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism That Mimics the Role of Activated RAS in Malignancy.
Manish Neupane, Allison P Clark, Serena Landini, Nicolai J Birkbak, Aron C Eklund, Daniel P Silver

Cancer Discov· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pan-cancer analysis of genomic scar signatures associated with homologous recombination deficiency suggests novel indications for existing cancer drugs.
Andrea M Marquard, Aron C Eklund, Tejal Joshi, Marcin Krzystanek, Francesco Favero, Daniel P Silver

Biomark Res· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRCA1 pathway function in basal-like breast cancer cells.
Sarah J Hill, Allison P Clark, Daniel P Silver, David M Livingston

Mol Cell Biol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of BRCA1 tumor suppression.
Daniel P Silver, David M Livingston

Cancer Discov· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Telomeric allelic imbalance indicates defective DNA repair and sensitivity to DNA-damaging agents.
Nicolai J Birkbak, Zhigang C Wang, Ji-Young Kim, Aron C Eklund, Qiyuan Li, Daniel P Silver

Cancer Discov· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chek2 DNA damage response pathway and inherited breast cancer risk.
Nadine Tung, Daniel P Silver

J Clin Oncol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-associated breast cancers.
Nadine Tung, Alexander Miron, Stuart J Schnitt, Shiva Gautam, Katharina Fetten, Daniel P Silver

Breast Cancer Res· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poly ADP-ribose polymerase inhibitors: science and current clinical development.
Joyce F Liu, Daniel P Silver

Curr Opin Oncol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poly(ADP-Ribose) polymerase inhibition: "targeted" therapy for triple-negative breast cancer.
Carey K Anders, Eric P Winer, James M Ford, Rebecca Dent, Daniel P Silver

Clin Cancer Res· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer.
Daniel P Silver, Andrea L Richardson, Aron C Eklund, Zhigang C Wang, Zoltan Szallasi

J Clin Oncol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complex landscapes of somatic rearrangement in human breast cancer genomes.
Philip J Stephens, David J McBride, Meng-Lay Lin, Ignacio Varela, Erin D Pleasance, Daniel P Silver

Nature· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen receptor-negative breast cancer: new insights into subclassification and targeting.
Jean J Zhao, Daniel P Silver

Clin Cancer Res· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthetic lethality--a new direction in cancer-drug development.
J Dirk Iglehart, Daniel P Silver

N Engl J Med· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclin A is redundant in fibroblasts but essential in hematopoietic and embryonic stem cells.
Ilona Kalaszczynska, Yan Geng, Tadafumi Iino, Shin-ichi Mizuno, Yoon Choi, Daniel P Silver

Cell· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis